Free Access
Editorial
Issue
Réanimation
Volume 25, Juillet 2016
Médecine interne et transversalité
Page(s) S115 - S118
Section Éditorial / Editorial
DOI https://doi.org/10.1007/s13546-016-1192-5
Published online 07 April 2016
  • Bennett JM, Catovsky D, Daniel MT, et al (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 33:451–8 [CrossRef] [PubMed] [Google Scholar]
  • Yanada M, Matsuo K, Suzuki T, et al (2005) Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis. Leukemia 19:1345–9 [CrossRef] [PubMed] [Google Scholar]
  • Thiede C, Koch S, Creutzig E, et al (2006) Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood 107:4011–20 [CrossRef] [PubMed] [Google Scholar]
  • Renneville A, Boissel N, Gachard N, et al (2009) The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication. Blood 113:5090–3 [CrossRef] [PubMed] [Google Scholar]
  • Patel JP, Gonen M, Figueroa ME, et al (2012) Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. The New England journal of medicine 366:1079–89 [CrossRef] [PubMed] [Google Scholar]
  • Bruggemann M, Raff T, Kneba M (2012) Has MRD monitoring superseded other prognostic factors in adult ALL? Blood 120:4470–81 [CrossRef] [PubMed] [Google Scholar]
  • Beldjord K, Chevret S, Asnafi V, et al (2014) Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. Blood 123:3739–49 [CrossRef] [PubMed] [Google Scholar]
  • Baccarani M, Deininger MW, Rosti G, et al (2013) European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood 122:872–84 [CrossRef] [PubMed] [Google Scholar]
  • Azoulay E, Mokart D, Pene F, et al (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a “groupe de recherche respiratoire en réanimation onco-hématologique” study. J Clin Oncol 31:2810–8 [CrossRef] [PubMed] [Google Scholar]
  • Azoulay E, Pene F, Darmon M, et al (2015) Managing critically ill hematology patients: Time to think differently. Blood Rev 29:359–67 [CrossRef] [PubMed] [Google Scholar]
  • Mamez AC, Raffoux E, Chevret S, et al (2016) Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia. Leuk Lymphoma 5:1–8 [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.